ArticleMolecular cancer therapeutics2013

A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface.

Zhewei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.